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Using a comprehensive proteomic approach, Schwenk et al. (2014), in this issue of Neuron, resolve the
differential composition of AMPA receptor complexes in brain regions and through development. This
work reveals a specificity in AMPA receptor complex assembly that is dynamic in both space and time.Proteomic approaches have transformed
our understanding of howproteins interact
to form functional units in cells. In par-
ticular, the characterization of multipro-
tein complexes by affinity purification
and mass spectrometry has been incred-
ibly useful to understand how molecular
functions are coordinated and regulated
by sets of gene products. Multiprotein
complexes can range from the relatively
small with few components, to molecular
machines such as the proteasome, to
larger assemblies or supercomplexes
within the postsynaptic density. Purifica-
tion of membrane-associated protein
complexes makes the definition of the
complex rather dependent on the strin-
gency of the isolation methods, particu-
larly the use of detergents, which can
certainly influence the recovery of native
complexes. However, this approach has
been successfully used to characterize
many important protein complexes in the
brain, particularly those associated with
a variety of ion channels such as NMDA
(Husi et al., 2000; Collins et al., 2006) and
AMPA receptors (Kang et al., 2012;
Schwenk et al., 2012; Schwenk et al.,
2009; von Engelhardt et al., 2010). NMDA
receptors associate with a large number
of proteins that can directly regulate ion
channel gating or regulate the trafficking
and stability of receptors in membrane
subdomains. Together with scaffolding
proteins and other signaling molecules,
these protein assembles orchestrate
many aspects of signal transduction in
glutamatergic synapses. In fact, such
complexes appear to be hot spots for
neurological diseases with numerous
genes associated with disorders, such as
schizophrenia, and the biochemical defini-
tion of these sets of proteins as complexes
is proving useful for overlaying data fromhuman genetics studies, allowing connec-
tions between rare mutations to be made
(Purcell et al., 2014).
Compared to NMDA receptors, AMPA
receptors appear to form more discrete
protein complexes which are composed
of the pore-forming subunits and mem-
bers of at least three families of auxiliary
subunits which together compose the in-
ner core of the complex. Over the years,
a growing list of proteins have been shown
to interact with AMPA receptors, but it
was only recently that comprehensive
proteomic analyses of AMPA receptor
complexes were reported. Schwenk et al.
generated a comprehensive blueprint for
an averageAMPA receptor (AMPAR) com-
plex purified from whole brain tissue us-
ing a combination of multiepitope affinity
purification of complexes, native gel elec-
trophoresis, and quantitative mass spec-
trometry (Schwenk et al., 2012). At the
same time, Shanks et al. reported a
comparative, quantitative proteomic anal-
ysis of both AMPA and kainite receptor
complexes (Shanks et al., 2012). Both of
these studies confirmed the presence of
many known components, identified novel
subunits of AMPAR complexes, and to-
gether generated valuable data sets for
the community.
The dynamic composition of multipro-
tein complexes is generally poorly charac-
terized and is a dimension that must be
explored in order to understand functional
differences of complexes in different
contexts. This is especially important for
protein complexes that are differentially
expressed across brain regions and cell
types, such as the AMPAR complex.
Furthermore, aspects of AMPA receptor
function are variable in different brain re-
gions, cell types, and individual synapses,
a feature that is likely determined by het-Neuronerogeneity of AMPAR complex compo-
sition and posttranslational regulation.
While itmay be possible to infer likely brain
region specificity for some components of
the AMPAR complex from gene expres-
sion atlases and immunohistochemistry
data, this approach comes with usual ca-
veats of incomplete coverage, incomplete
correlation between RNA and protein
expression levels, and potential crossre-
activity of antibodies. Critically, the com-
position of the complex in the context of
all constituent components and asso-
ciated protein interactions cannot be
accurately predicted. Therefore, to fully
understand the composition of a protein
complex and heterogeneity of a complex
in different contexts, it would be very
desirable to directly measure the levels
of all components in an unbiased way.
In this issue of Neuron, Schwenk et al.
(2014) explore the diversity of AMPAR
complexes across different brain regions
and through development using functional
proteomics (Figure 1). Using an approach
that they have previously employed (Sch-
wenk et al., 2012) which utilizes antibodies
directed at all four pore-forming subunits,
the authors were able to purify the entire
complement of AMPAR complexes from
brain tissue samples. This is particularly
important for comparing composition of
complexes in different brain regions in
which different combinations of subunits
predominate. AMPAR complexeswere af-
finity purified frommembrane lysates from
dissected rat brain regions (olfactory bulb,
cortex, striatum, thalamus, hippocampus,
brainstem, and cerebellum) and analyzed
by nanoscale liquid chromatography tan-
dem mass spectrometry (LC-MS/MS).
In this approach, protein samples are
enzymatically digested into short pepti-
des, chromatographically separated, and84, October 1, 2014 ª2014 Elsevier Inc. 1
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Figure 1. Heterogeneity of AMPA Receptor Complexes
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Previewsdelivered to a mass spectrometer by elec-
trospray ionization. Mass/charge measu-
rements of the intact peptides and of their
fragments obtained via gas phase dis-
sociation permit their identification and
quantification and inference of respective
proteins and their relative abundance
across samples.
The analysis of complexes purified from
different brain regionswas restricted to the
set of 34 robustly enriched components of
the AMPAR complex from their previous
characterization of complexes purified
from whole brains (Schwenk et al., 2012).
It should be noted that this approach
may have missed proteins only detectable
when purified from specific brain regions
that were not identified in complexes puri-
fied from whole brains due to dynamic
range issues. A library of peptides derived
from AMPAR complex constituents were
expressed as QconCAT proteins, which
are concatenated peptide sequences
made into artificial proteins to serve as
peptide quantification standards (Beynon
et al., 2005). This allowed the molecular
abundance of each protein to be calcu-
lated, which would indicate the average
stoichiometry of a given component2 Neuron 84, October 1, 2014 ª2014 Elsevieracross the pool of AMPARs expressed in
a brain region. This permitted the density
of the pore-forming subunits to be cal-
culated for each tissue, with the cortex
containing 50% of all AMPARs and the
hippocampus containing 40%. Impor-
tantly, the combinations of pore-forming
subunits displayed considerable regional
specificity particularly between the hippo-
campus and the cerebellum and a differ-
ential use of the auxiliary subunits CNIH2
and TARPs. Strikingly, all 34 components
displayed considerable variations in their
profile of association with the AMPAR
complex, an observation which clearly de-
monstrates the utility of the approach but
also the potential for functional hetero-
geneity of AMPAR complexes in different
brain regions, especially when combinato-
rial effects are considered.
In order to derive relationships between
the amounts of AMPAR complex proteins
and specific assemblies of pore-forming
subunits, the abundance values were
normalized to the total number of GluA
tetramers in each brain region. This
normalized abundance value can be
considered as the average stoichiometry
of each complex constituent or the prob-Inc.ability of incorporation into the complex.
This showed considerable diversity in
the subunit composition for the pore-
forming and auxiliary subunits. In the
hippocampus TARP g-8 and CNIH2 are
present in the complex at similar amounts
and are the predominant auxiliary sub-
units, while in the cerebellum, TARP g-2
and TARP g-7 dominate. Interestingly,
the profile of certain components appears
to be correlated: GluRA4 precludes as-
sembly of TARP g-8, and assembly of
CNIH2 is determined by the sum of
GluA1 and GluA2. In all brain regions
except the cerebellum and brainstem,
the data supported an inner core architec-
ture of four inner core components which
bind at two separate pairs of sites. In the
cerebellum and brainstem, the number
of inner core components was two, indi-
cating a differential composition of the
complex. This was investigated in more
detail using antibody shift assays on
native gels which allow the composition
of intact complexes to be inferred by the
observation of a mobility shift caused by
antibody binding to the complex. In the
hippocampus, almost all complexes
contain several GluA1 and/or GluA2 sub-
units, CNIH2 and TARP g-8 and/or TARP
g-2/3, whilst in the cerebellum these sub-
units are found in a small fraction of com-
plexes. Using serial affinity purifications, it
was demonstrated that in the cerebellum,
the predominant pore-forming subunit
GluA4 mostly assembles into complexes
with GluA1, and these complexes lack
inner core components, confirming the re-
duced amount of these subunits obser-
ved in the cerebellum.
While the resolution of protein com-
plexes to the level of brain regions is
very useful, it is clear that this still repre-
sents an average AMPAR complex, and
in order to assess the extent of averaging,
the authors scaled down their proteomic
approach to analyses complexes purified
from 200 mm micropunches from three
subregions (stratum radiatum of the hip-
pocampal CA3 region, themolecular layer
of the cerebellum, and the nucleus ac-
cumbens in the striatum) that would con-
tain fewer cell types. Impressively, they
were able to identify and quantify all
AMPAR complex components from these
minute tissue samples and demonstrated
that, by and large, complexes isolated
from intact brain regions were similar to
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Previewsthose purified from subregions. A number
of exceptions were identified for non-
pore-forming subunits, and it is very likely
that the number of these exceptions
would increase with increased tissue/
cellular resolution. A recurring problem
with affinity purification-mass spectrom-
etry approaches is that it is not possible
to differentiate between coassembly of
proteins within the same complex and co-
expression of complexes with different
components. The authors have attemp-
ted to disentangle this by Pearson corre-
lation analysis of their data and propose
that robustly correlated proteins likely
represent coassembly. Highly correlated
sets of subunits included PRRT1 and
CNIH2 and GluA3, GSG1l and CKAMP44
and DLG4. Negatively correlated proteins
represent subunits that disfavor coas-
sembly and included TARPs g-5 and
g-7, which are negatively correlated with
GluA2 but are highly correlated with
GluR4.
Finally, the same proteomic approach
was used to quantify the relative compo-
sition of AMPAR complexes in whole rat
brains through a four-stage develop-
mental time course (P0–P3, P7, P14, and
p > 28). This revealed an intriguing set of
profiles that varied over time, with evi-
dence of transient association with the
complex and inverse profiles in which
components were replaced by other
related proteins during development.
The pore-forming subunits, however, re-
mained relatively constant through thedevelopmental time course, although a
small antiparallel relationship between
GluA2 and GluA4 and GluA1 and GluA3
was evident.
The present study is clearly an im-
pressive demonstration of the power of
state-of-the-art functional proteomics,
and data sets generated will be a very
useful resource to the neuroscience com-
munity, particularly for in-depth follow-up
studies to correlate differential composi-
tion with differential function of AMPA
receptors in different brain regions and
cell types. The observation of AMPAR
complex heterogeneity in brain regions
and in development prompts many ques-
tions. To what extent are AMPAR com-
plexes heterogeneous in different cell
types? The use of epitope-tagged recep-
tors expressed in a cell-specific manner
might allow this question to be ad-
dressed. Are AMPAR complexes different
between synapses or even between spe-
cific assemblies in the same synapse? If
we were to investigate posttranslational
modifications of AMPAR receptor com-
ponents, to what extent would this extend
heterogeneity? Hints of this can be seen
in the phosphorylation site profiles
generated in the present study, but it is
very likely the combinatorial effect of
posttranslational modifications such as
phosphorylation, ubiquitination, palmitoy-
lation, glycosylation, and acetylation,
among others, would extend the opportu-
nity for AMPAR complex heterogeneity
very significantly. Ultimately, measure-Neuronment of compositional and modification
state dynamics of AMPAR complexes in
response to neuronal activity would allow
the functional significance of heterogene-
ity to be investigated.
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